g logo ipb green

Overview

This algorithm can be used as a guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease—namely coronary artery disease, peripheral arterial disease, and cerebrovascular disease.

This Guidelines summary has been reproduced with permission from the Cardio-Renal-Metabolic (CaReMeUK) partnership of the Association of British Clinical Diabetologists, the British Cardiovascular Society, the Primary Care Cardiovascular Society, the Primary Care Diabetes Society, and the Renal Association.

View this summary online at guidelines.co.uk/455896.article

Algorithm 1: Cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease

CaReMe CVD risk in T2D algorithmv2

Full guideline:

Cardio-Renal-Metabolic (CaReMeUK) partnership. Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 diabetes and atherosclerotic cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebrovascular disease). CaReMeUK, 2021.
Available at: britishcardiovascularsociety.org/resources/careme

Published date: April 2021.